OpenBilldrug price receipt

NADAC week of 2026-10-14

HYLENEX 150 UNITS/ML VIAL

FDA nonproprietary name: hyaluronidase

For 4 mL

Pharmacies pay

$214.75 filed

4 × $53.68773 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part B pays

$218.40 derived

4 × $54.60 per ML, Part B limit

Medicare's price is not your price.

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)


The spread

1.0× estimated

Medicare pays about what pharmacies pay.

2 labelers share HCPCS J3473 on the CMS crosswalk, so its payment limit is an average across all their products billed under that code, not this NDC’s own price.

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Cost-plus estimate

$251.96 estimated

$214.75 + $32.21 (15%) + $5.00 fee per fill = $251.96

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

HYLENEX 150 UNITS/ML VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as hyaluronidase, under the trade name “HYLENEX Recombinant”.

FDA gives its dosage form as injection, solution and its route as subcutaneous.

The labeler, the company named on the label, is Antares Pharma, Inc.

FDA’s Established Pharmacologic Class for it is Endoglycosidase.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 18657-0117-04.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $214.75 for 4 mL (4 × $53.68773 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

The NDC

What Medicare paid

Medicare Part B’s payment limit for HCPCS J3473, for 2026-10-01 to 2026-12-31, comes to $218.40 for 4 mL, or $54.60 per ML once converted to NADAC’s unit for this product.

Medicare Part B pays for a drug like this only in specific settings, such as a drug given in a clinic or doctor’s office or used with certain medical equipment; most prescriptions filled at a pharmacy are paid by Part D.

The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.0728 per 1 USP UNIT.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 4 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 4 mL in one package for this product’s NDC (“4 BOX in 1 CARTON (18657-117-04) / 1 VIAL in 1 BOX (18657-117-02) / 1 mL in 1 VIAL (18657-117-01)”), so the card starts at one package: 4 ML. Change it to match your prescription.